Skip to main content
TipRanks
Go Ultimate75% OFF

Spero Therapeutics (2HA) Q4 2024 Earnings Report

2 Followers

DE:2HA Q4 2024 EPS Results

Actual EPS
-EUR 0.34
Consensus EPS
-EUR 0.28
Beat/Miss
Missed by -EUR 0.06
One Year Ago EPS
EUR 0.87

DE:2HA Q4 2024 Revenue Results

Actual Revenue
EUR 8.49M
Expected Revenue
EUR 11.25M
Beat/Miss
Missed by -EUR 2.76M
YoY Revenue Growth
-86.97%

Earnings Announcement Details

Quarter
Q4 2024
Date
03/27/2025
Time
After Close
Conference Call
Thursday, March 27, 2025
DE:2HA Upcoming Earnings

Spero Therapeutics's next earnings date is estimated for April 1, 2027, based on past reporting schedules.

Q4 2024 Earnings Call Audio

DE:2HA Q4 2024 Earnings Call
0:00 / 0:00

Q4 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:2HA Earnings History

DE:2HA earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 01, 20272026 (Q4)-0.17--0.12――
Nov 12, 20262026 (Q3)-0.43-0.69-0.12-484.62% (-0.57)
Aug 12, 20262026 (Q2)―-0.15-0.03-433.33% (-0.12)
May 13, 20262026 (Q1)―-0.12-0.2348.00% (+0.11)
Mar 26, 20262025 (Q4)-0.180.48-0.34239.47% (+0.83)
Nov 13, 20252025 (Q3)-0.23-0.12-0.2959.38% (+0.17)
Aug 12, 20252025 (Q2)-0.34-0.03-0.390.91% (+0.27)
May 13, 20252025 (Q1)-0.50-0.23-0.22-4.17% (-0.01)
Mar 27, 20252024 (Q4)-0.28-0.340.87-139.58% (-1.22)
Nov 14, 20242024 (Q3)-0.24-0.29-0.05-433.33% (-0.24)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed